Détail de l'auteur
Auteur L. DEGENHARDT |
Documents disponibles écrits par cet auteur (121)
Livre
Chapitre
Cannabis is the illicit drug that is most often used by adolescents and the one that young people are most likely to develop dependence on. Cannabis dependence is more common in males, especially those who display disruptive and antisocial behav[...]Périodique
W. HALL ; L. DEGENHARDT | 2009ENGLISH : For over two decades, cannabis, commonly known as marijuana, has been the most widely used illicit drug by young people in high-income countries, and has recently become popular on a global scale. Epidemiological research during the [...]Périodique
Age differentials in the impacts of reduced heroin: Effects of a "heroin shortage" in NSW, Australia
L. DEGENHARDT ; C. DAY ; CONROY E. ; S. GILMOUR ; W. HALL | 2005ENGLISH : Background: This paper uses a unique event, the Australian heroin shortage, to see whether an abrupt, substantial and sustained change in heroin supply had different effects on harms related to heroin use among younger and older hero[...]Article : Périodique
C. BHARAT ; P. WEBB ; Z. WILKINSON ; R. McKETIN ; J. GREBELY ; M. FARRELL ; A. HOLLAND ; M. HICKMAN ; L. T. TRAN ; B. CLARK ; A. PEACOCK ; S. DARKE ; J. H. LI ; L. DEGENHARDT |BACKGROUND AND AIMS: Studies often rely upon self-report and biological testing methods for measuring illicit drug use, although evidence for their agreement is limited to specific populations and self-report instruments. We aimed to examine com[...]Périodique
L. DEGENHARDT ; W. HALL ; M. LYNSKEY | 2001ENGLISH : Aim. To compare relationships between alcohol, cannabis and tobacco and indicators of mental health problems in the general population. Method. A survey of a nationally representative sample of 10 641 Australian adults (the National [...]Périodique
C. BREEN ; L. DEGENHARDT ; S. KINNER ; R. BRUNO ; R. JENKINSON ; A. MATTHEWS ; J. NEWMAN | 2006ENGLISH : We examine alcohol use in conjunction with ecstasy use and risk-taking behaviors among regular ecstasy users in every capital city in Australia. Data on drug use and risks were collected in 2004 from a national sample of 852 regular [...]Article : Périodique
The Eleventh Revision of the International Classification of Diseases (ICD-11) was formally published in May 2019. Alcohol use disorders form a key part of the section of Disorders due to Substance Use and Addictive Behaviours. This review descr[...]Article : Périodique
A. PEACOCK ; L. T. TRAN ; S. LARNEY ; E. STOCKINGS ; T. SANTO ; H. JONES ; D. SANTOMAURO ; L. DEGENHARDT |AIMS: To estimate pooled all-cause and cause-specific mortality risk for people with regular or problematic cocaine use. METHODS: Systematic review and meta-analysis of prospective or retrospective cohort studies or clinical trials (n > = 30) o[...]Périodique
J. McGRATH ; J. WELHAM ; J. SCOTT ; D. VARGHESE ; L. DEGENHARDT ; M. R. HAYATBAKHSH ; R. ALATI ; G. M. WILLIAMS ; W. BOR ; J. M. NAJMAN | 2010Context: Prospective cohort studies have identified an association between cannabis use and later psychosis-related outcomes, but concerns remain about unmeasured confounding variables. The use of sibling pair analysis reduces the influence of u[...]Article : Périodique
L. A. HINES ; A. TRICKEY ; J. LEUNG ; S. LARNEY ; A. PEACOCK ; L. DEGENHARDT ; S. COLLEDGE ; M. HICKMAN ; J. GREBELY ; E. B. CUNNINGHAM ; J. STONE ; K. DUMCHEV ; P. GRIFFITHS ; P. VICKERMAN ; R. P. MATTICK ; M. LYNSKEY |BACKGROUND: Globally, an estimated 15.6 million people inject drugs. We aimed to investigate global variation in the age profile of people who inject drugs (PWID), identify country-level factors associated with age of PWID, and assess the associ[...]Rapport
A. PEACOCK ; J. UPOROVA ; A. KARLSSON ; O. PRICE ; D. GIBBS ; R. SWANTON ; R. CHAN ; R. BRUNO ; P. DIETZE ; S. LENTON ; C. SALOM ; L. DEGENHARDT ; M. FARRELL | Sydney : National Drug and Alcohol Research Centre, University of New South Wales | 2021The Illicit Drug Reporting System (IDRS) is a national illicit drug monitoring system intended to identify emerging trends of local and national concern in illicit drug markets, and forms part of Drug Trends. The IDRS consists of annual intervie[...]Rapport
M. DUNN ; L. DEGENHARDT ; G. CAMPBELL ; J. GEORGE ; J. JOHNSTON ; S. KINNER ; A. MATTHEWS ; J. NEWMAN ; N. WHITE | Sydney : NDARC (National Drug and Alcohol Research Centre) | 2007The Australian Drug Trends 2006 report presents the findings from the fourth year in which data has been collected in all states and territories in Australia on the markets for ecstasy and related drugs. The Ecstasy and Related Drugs Reporting S[...]Article : Périodique
L. DEGENHARDT ; B. CLARK ; G. MACPHERSON ; O. LEPPAN ; S. NIELSEN ; E. ZAHRA ; B. LARANCE ; J. KIMBER ; D. MARTINO-BURKE ; M. HICKMAN ; M. FARRELL |Background: Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and buprenorphine are [...]Article : Périodique
N. BLACK ; E. STOCKINGS ; G. CAMPBELL ; L. T. TRAN ; D. ZAGIC ; W. D. HALL ; M. FARRELL ; L. DEGENHARDT |Background: Medicinal cannabinoids, including medicinal cannabis and pharmaceutical cannabinoids and their synthetic derivatives, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), have been suggested to have a therapeutic role in certain[...]Article : Périodique
W. SWIFT ; C. COFFEY ; L. DEGENHARDT ; J. B. CARLIN ; H. ROMANIUK ; G. C. PATTON |Background: Adolescent cannabis use predicts the onset of later illicit drug use. In contrast, little is known about whether cannabis in young adulthood also predicts subsequent progression or cessation of licit or illicit drug use. Methods: 1[...]Périodique
COFFREY C. ; J. B. CARLIN ; L. DEGENHARDT ; M. LYNSKEY ; SANCI L. ; G. C. PATTON | 2002FRANÇAIS : Dans une population représentative de 1601 jeunes adultes en 1998, l'usage de cannabis, les symptômes de dépendance et la différence de symptomatologie entre les syndromes alcoolique et cannabique sont étudiés. 59% rapportent une con[...]Périodique
G. C. PATTON ; C. COFFEY ; J. B. CARLIN ; L. DEGENHARDT ; M. LYNSKEY ; W. HALL | 2002ENGLISH : Objective. To determine whether cannabis use in adolescence predisposes to higher rates of depression and anxiety in young adulthood. Design. Seven wave cohort study over six years. Setting. 44 schools in the Australian state of Vict[...]Article : Périodique
L. DEGENHARDT ; S. LARNEY ; D. RANDALL ; L. BURNS ; W. HALL |Aims: To examine changes in causes of death in a cohort treated for opioid dependence, across time and age; quantify years of potential life lost (YPLL); and identify avoidable causes of death. Design: People in New South Wales (NSW) who regist[...]Périodique
A. ROXBURGH ; L. DEGENHARDT ; C. BREEN | 2004ENGLISH : The aim of this study was to examine changes in drug use patterns among groups of injecting drug users (IDU) who remained in the drug market during a period of reduced heroin availability in NSW, Australia. Cross-sectional data colle[...]Article : Périodique
L. SORDO ; B. I. INDAVE ; G. BARRIO ; L. DEGENHARDT ; L. DE LA FUENTE ; M. J. BRAVO |Background: Both cocaine use and strokes impact public health. Cocaine is a putative cause of strokes, but no systematic review of the scientific evidence has been published. Methods: All relevant bibliographic-databases were searched until Ja[...]Périodique
J. H. JAFFE ; M. GOSSOP ; M. TYNDALL ; R. E. MANN ; P. REUTER ; W. HAO ; D. WEATHERBURN ; J. P. CAULKINS ; L. DEGENHARDT ; W. HALL ; C. DAY ; P. DIETZE ; L. COLLINS ; POINTER S. | 2005Neuf commentaires sont proposés. Le premier, au regard des résultats de cette étude analyse un événement similaire survenu aux Etats-Unis en 1972/1973. Le deuxième s'intéresse aux conséquences du transfert de l'usage injectable d'héroïne vers l'[...]Article : Périodique
S. NIELSEN ; N. MENON ; S. LARNEY ; M. FARRELL ; L. DEGENHARDT |Aim: Given the potential to expand naloxone supply through community pharmacy, the aim of this study was to estimate Australian pharmacists': (1) level of support for overdose prevention, (2) barriers and facilitators for naloxone supply and (3)[...]Rapport
L. DEGENHARDT ; C. HALLAM ; D. R. BEWLEY-TAYLOR | Oxford : The Beckley Foundation Drug Policy Programme | Briefing Paper | 2009This paper seeks to compare the drugs situation in a number of developed countries. Data from eight indicators are for the first time compared across six European countries (Denmark, Germany, The Netherlands, Portugal, Sweden, the United Kingdom[...]Article : Périodique
L. DEGENHARDT ; C. BHARAT ; R. BRUNO ; M. D. GLANTZ ; N. A. SAMPSON ; L. LAGO ; S. AGUILAR-GAXIOLA ; J. ALONSO ; L. H. ANDRADE ; B. BUNTING ; J. M. CALDAS-DE-ALMEIDA ; A. H. CIA ; O. GUREJE ; E. G. KARAM ; M. KHALAF ; J. J. MCGRATH ; J. MOSKALEWICZ ; S. LEE ; Z. MNEIMNEH ; F. NAVARRO-MATEU ; C. C. SASU ; K. SCOTT ; Y. TORRES ; V. POZNYAK ; S. CHATTERJI ; R. C. KESSLER ; WHO World Mental Health Survey Collaborators |BACKGROUND AND AIMS: The World Health Organization's (WHO's) proposed International Classification of Diseases, 11th edition (ICD-11) includes several major revisions to substance use disorder (SUD) diagnoses. It is essential to ensure the consi[...]